Lonza Posts Strong CDMO Performance In Q1 2025

Reuters

May 09

May 9 (Reuters) - LONZA GROUP AG ::
*STRONG CDMO^1 PERFORMANCE IN Q1 2025, IN LINE WITH EXPECTATIONS FOR FY 2025
*CDMO OUTLOOK 2025 CONFIRMED WITH CER^2 SALES GROWTH APPROACHING 20% AND CORE EBITDA MARGIN APPROACHING 30%
*CHI CONFIRMS ITS OUTLOOK TO RETURN TO LOW-TO-MID-SINGLE-DIGIT CER SALES GROWTH IN 2025 WITH AN IMPROVING CORE EBITDA MARGIN IN MID-TWENTIES
*MID-TERM OUTLOOK CONFIRMED
*Q1 2025, LONZA EXPERIENCED A HEALTHY LEVEL OF CONTRACT SIGNINGS ACROSS WHOLE CDMO BUSINESS
*DOES NOT ANTICIPATE A MATERIAL FINANCIAL IMPACT FROM POTENTIAL TARIFFS
*LONZA NOW ANTICIPATES START OF OPERATIONS AT ITS NEW COMMERCIAL-SCALE ASEPTIC DRUG PRODUCT FACILITY IN STEIN (CH) IN 2027
*IN Q1 2025, LONZA EXPERIENCED A HEALTHY LEVEL OF CONTRACT SIGNINGS ACROSS WHOLE CDMO BUSINESS
*CUSTOMER INTEREST IN VACAVILLE IS STRONG, WITH A THIRD LONG-TERM CUSTOMER CONTRACT SECURED AND A NUMBER OF CONTRACT NEGOTIATIONS ONGOING
*MAKING GOOD PROGRESS WITH PREPARATIONS FOR EXIT OF CHI BUSINESS
*CHI BUSINESS: CURRENTLY PLANNING NECESSARY CARVE-OUT MEASURES

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 09-MAY-202504:30:26.66 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2534460971"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2534460971\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2534460971?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-09 12:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534460971","market":"nz","top_or_hot":-1,"title":"Lonza Posts Strong CDMO Performance In Q1 2025","media":"Reuters","content":"<html><body>May 9 (Reuters) - LONZA GROUP AG <lonn.s>::<br/>*STRONG CDMO^1 PERFORMANCE IN Q1 2025, IN LINE WITH EXPECTATIONS FOR FY 2025<br/>*CDMO OUTLOOK 2025 CONFIRMED WITH CER^2 SALES GROWTH APPROACHING 20% AND CORE EBITDA MARGIN APPROACHING 30%<br/>*CHI CONFIRMS ITS OUTLOOK TO RETURN TO LOW-TO-MID-SINGLE-DIGIT CER SALES GROWTH IN 2025 WITH AN IMPROVING CORE EBITDA MARGIN IN MID-TWENTIES<br/>*MID-TERM OUTLOOK CONFIRMED<br/>*Q1 2025, LONZA EXPERIENCED A HEALTHY LEVEL OF CONTRACT SIGNINGS ACROSS WHOLE CDMO BUSINESS<br/>*DOES NOT ANTICIPATE A MATERIAL FINANCIAL IMPACT FROM POTENTIAL TARIFFS<br/>*LONZA NOW ANTICIPATES START OF OPERATIONS AT ITS NEW COMMERCIAL-SCALE ASEPTIC DRUG PRODUCT FACILITY IN STEIN (CH) IN 2027<br/>*IN Q1 2025, LONZA EXPERIENCED A HEALTHY LEVEL OF CONTRACT SIGNINGS ACROSS WHOLE CDMO BUSINESS<br/>*CUSTOMER INTEREST IN VACAVILLE IS STRONG, WITH A THIRD LONG-TERM CUSTOMER CONTRACT SECURED AND A NUMBER OF CONTRACT NEGOTIATIONS ONGOING<br/>*MAKING GOOD PROGRESS WITH PREPARATIONS FOR EXIT OF CHI BUSINESS<br/>*CHI BUSINESS: CURRENTLY PLANNING NECESSARY CARVE-OUT MEASURES<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 09-MAY-202504:30:26.66 GMT</lonn.s></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lonza Posts Strong CDMO Performance In Q1 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLonza Posts Strong CDMO Performance In Q1 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-09 12:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>May 9 (Reuters) - LONZA GROUP AG <lonn.s>::<br/>*STRONG CDMO^1 PERFORMANCE IN Q1 2025, IN LINE WITH EXPECTATIONS FOR FY 2025<br/>*CDMO OUTLOOK 2025 CONFIRMED WITH CER^2 SALES GROWTH APPROACHING 20% AND CORE EBITDA MARGIN APPROACHING 30%<br/>*CHI CONFIRMS ITS OUTLOOK TO RETURN TO LOW-TO-MID-SINGLE-DIGIT CER SALES GROWTH IN 2025 WITH AN IMPROVING CORE EBITDA MARGIN IN MID-TWENTIES<br/>*MID-TERM OUTLOOK CONFIRMED<br/>*Q1 2025, LONZA EXPERIENCED A HEALTHY LEVEL OF CONTRACT SIGNINGS ACROSS WHOLE CDMO BUSINESS<br/>*DOES NOT ANTICIPATE A MATERIAL FINANCIAL IMPACT FROM POTENTIAL TARIFFS<br/>*LONZA NOW ANTICIPATES START OF OPERATIONS AT ITS NEW COMMERCIAL-SCALE ASEPTIC DRUG PRODUCT FACILITY IN STEIN (CH) IN 2027<br/>*IN Q1 2025, LONZA EXPERIENCED A HEALTHY LEVEL OF CONTRACT SIGNINGS ACROSS WHOLE CDMO BUSINESS<br/>*CUSTOMER INTEREST IN VACAVILLE IS STRONG, WITH A THIRD LONG-TERM CUSTOMER CONTRACT SECURED AND A NUMBER OF CONTRACT NEGOTIATIONS ONGOING<br/>*MAKING GOOD PROGRESS WITH PREPARATIONS FOR EXIT OF CHI BUSINESS<br/>*CHI BUSINESS: CURRENTLY PLANNING NECESSARY CARVE-OUT MEASURES<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 09-MAY-202504:30:26.66 GMT</lonn.s></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4006","symbol_name":"钢铁","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nRSD8J2ml1:1","article_id":"2534460971","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534460971","pubTimestamp":1746766031,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"May 9 (Reuters) - LONZA GROUP AG ::*STRONG CDMO^1 PERFORMANCE IN Q1 2025, IN LINE WITH EXPECTATIONS FOR FY 2025*CDMO OUTLOOK 2025 CONFIRMED WITH CER^2 SALES GROWTH APPROACHING 20% AND CORE EBITDA MARG","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4006":"钢铁","LU0882574139.USD":"富达环球消费行业基金A ACC","LU0149725797.USD":"汇丰美国股市经济规模基金","IE00BHPRN162.USD":"BNY MELLON BLOCKCHAIN INNOVATION \"B\" (USD) ACC","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","CMC":"美国工商五金公司","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0971096721.USD":"富达环球金融服务 A","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC"},"translate_title":"龙沙2025年第一季度CDMO业绩强劲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CMC":0.9},"content_text":"May 9 (Reuters) - LONZA GROUP AG ::*STRONG CDMO^1 PERFORMANCE IN Q1 2025, IN LINE WITH EXPECTATIONS FOR FY 2025*CDMO OUTLOOK 2025 CONFIRMED WITH CER^2 SALES GROWTH APPROACHING 20% AND CORE EBITDA MARGIN APPROACHING 30%*CHI CONFIRMS ITS OUTLOOK TO RETURN TO LOW-TO-MID-SINGLE-DIGIT CER SALES GROWTH IN 2025 WITH AN IMPROVING CORE EBITDA MARGIN IN MID-TWENTIES*MID-TERM OUTLOOK CONFIRMED*Q1 2025, LONZA EXPERIENCED A HEALTHY LEVEL OF CONTRACT SIGNINGS ACROSS WHOLE CDMO BUSINESS*DOES NOT ANTICIPATE A MATERIAL FINANCIAL IMPACT FROM POTENTIAL TARIFFS*LONZA NOW ANTICIPATES START OF OPERATIONS AT ITS NEW COMMERCIAL-SCALE ASEPTIC DRUG PRODUCT FACILITY IN STEIN (CH) IN 2027*IN Q1 2025, LONZA EXPERIENCED A HEALTHY LEVEL OF CONTRACT SIGNINGS ACROSS WHOLE CDMO BUSINESS*CUSTOMER INTEREST IN VACAVILLE IS STRONG, WITH A THIRD LONG-TERM CUSTOMER CONTRACT SECURED AND A NUMBER OF CONTRACT NEGOTIATIONS ONGOING*MAKING GOOD PROGRESS WITH PREPARATIONS FOR EXIT OF CHI BUSINESS*CHI BUSINESS: CURRENTLY PLANNING NECESSARY CARVE-OUT MEASURES  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 09-MAY-202504:30:26.66 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}